Search by Drug Name or NDC

    NDC 67877-0727-30 Venlafaxine 75 mg/1 Details

    Venlafaxine 75 mg/1

    Venlafaxine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is VENLAFAXINE HYDROCHLORIDE.

    Product Information

    NDC 67877-0727
    Product ID 67877-727_44843f8f-a4f3-4035-b927-1c5671335fb1
    Associated GPIs 58180090107520
    GCN Sequence Number 064445
    GCN Sequence Number Description venlafaxine HCl TAB ER 24 75 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 14352
    HICL Sequence Number 008847
    HICL Sequence Number Description VENLAFAXINE HCL
    Brand/Generic Generic
    Proprietary Name Venlafaxine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Venlafaxine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 75
    Active Ingredient Units mg/1
    Substance Name VENLAFAXINE HYDROCHLORIDE
    Labeler Name Ascend Laboratories, LLC
    Pharmaceutical Class Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214127
    Listing Certified Through 2024-12-31

    Package

    NDC 67877-0727-30 (67877072730)

    NDC Package Code 67877-727-30
    Billing NDC 67877072730
    Package 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-727-30)
    Marketing Start Date 2021-06-11
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.21733
    Pricing Unit EA
    Effective Date 2022-08-17
    NDC Description VENLAFAXINE HCL ER 75 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis